EIM Group
http://www.eimgroup.com/jahia/page2.htmlEIM Group is a fund of fund that focuses on identifying, screening, and analyzing the best fund managers in different markets and investment styles.
View Older Stories View More Recent Stories
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Sjóvá: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun
-
Form 4 Bristow Group Inc. For: Jun 12 Filed by: Stavley Stuart
-
Nova Klúbburinn hf.: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun
-
VÍS: Endanlega dagskrá og tillögur til hluthafafundar árið 2023
-
Nova Klúbburinn hf.: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
EIMSKIP: Results for Q1 2023
-
EIMA Announces Winners of EIFS Architectural Awards
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Herbalife Sponsors the California Academy of Nutrition and Dietetics Foundation Fundraiser at the LA Galaxy's Dignity Sports Park to Elevate Sports Nutrition for Professional Athletes
-
Regeneron (REGN) and Alnylam (ALNY) Report Positive Interim Phase 1 Clinical Data on ALN-APP
-
Eimskip: Total number of shares and voting right
-
Exclusive Networks: Statement of Transactions in Own Shares From March 20 to 24, 2023
-
CoPeace and KidGlov Announce Strategic Partnership
-
Kontoor Brands, Designing for a Better Tomorrow
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Form 497J VANGUARD OHIO TAX-FREE
-
Baylor University and Evidence In Motion Enter Agreement for Hybrid Graduate Health Care Programs
-
Royce Geo Selected for $900M IDIQ Contract to Support U.S. Space Force Data Software Services
-
Royce Geo Supports National Geospatial Intelligence Agency's Economic Indicator Monitoring Program
-
Eimskip: Reduction of share capital
-
XORTX Therapeutics Inc (XRTX) Announces Type D Meeting with FDA to be held May 1
-
Eimskip: Updated Financial Calendar 2023
-
Results of Eimskip's 2023 Annual General Meeting
-
Eimskip: Annual Report 2022
-
LEIÐRÉTTING: VÍS: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Eimskip: Candidates to the Board of Directors and 2023 AGM’s final agenda
-
Eimskip: AGM 2023 final agenda and proposals
-
Form 4 STREAMLINE HEALTH SOLUTI For: Feb 14 Filed by: Stilwill Benjamin Louis
-
Sjóvá: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun
-
Eimskip: Annual General Meeting 9 March 2023
-
EIMSKIP: RESULT FOR THE YEAR 2022
-
Cognition Therapeutics, Inc. (CGTX) receives Notice of Allowance for its US patent related to AD
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Docufree Wins 2022 Document Manager Award in "Enterprise CMS Product of the Year" Category
-
Disclosure of trading in own shares from January 16, 2023 to January 20, 2023
-
Eimskip: Major shareholder announcement from Stefnir
-
Eimskip: Information regarding Q4 results
-
Eimskip’s Nomination Committee is open for nominations
-
MorganFranklin Consulting Names Latest Class of New Leaders
-
Tilnefningarnefnd Sjóvár auglýsir eftir framboðum til stjórnar
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
-
Eimskip: Major shareholder announcement from Samherji Holding ehf. and A03 ehf.
-
Eimskip's Financial Calendar 2023
-
Frequency Electronics (FEIM) Declares $1.00 Special Dividend; 18.7% Yield
-
Nýr liðsfélagi í skemmtana- & framkvæmdastjórn Nova
-
Hexagon strengthens its physical security and incident management capabilities with the acquisition of Qognify
-
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

